Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome is characterized by osteoporosis, macrocephalus, brachytelephalangy, and hyperextensibility of the joints. Congenital amaurosis and intellectual deficit have also been reported. This syndrome has been described in three members of one family.
Biomarker and diagnostic research for osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome has been reported in the published literature.
No clinical trials have been registered for osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome.
46 publications have been identified in PubMed for osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome. Research spans Epidemiology / Natural History (28%), Case Report / Case Series (22%), and Other (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 13 | 28% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
10 |
22% |
Other research | 6 | 13% |
Research summaries | 6 | 13% |
Laboratory research | 6 | 13% |
Clinical study results | 3 | 7% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Diodato D (2026). [PMID: 41780226](https://pubmed.ncbi.nlm.nih.gov/41780226/). *Eur J Paediatr Neurol*. [Review / Meta-Analysis]
Di Donato N (2026). [PMID: 41529692](https://pubmed.ncbi.nlm.nih.gov/41529692/). *Am J Hum Genet*. [Basic Science / Preclinical]
Agarwal A (2026). [PMID: 41481487](https://pubmed.ncbi.nlm.nih.gov/41481487/). *Eur J Ophthalmol*. [Epidemiology / Natural History]
Shajahan A (2026). [PMID: 41909398](https://pubmed.ncbi.nlm.nih.gov/41909398/). *Cureus*. [Case Report / Case Series]
Jain NS (2026). [PMID: 40483709](https://pubmed.ncbi.nlm.nih.gov/40483709/). *Hand (N Y)*. [Epidemiology / Natural History]
Schilder MB (2026). [PMID: 42033789](https://pubmed.ncbi.nlm.nih.gov/42033789/). *J Magn Reson Imaging*. [Other]
Chretien M (2026). [PMID: 42186459](https://pubmed.ncbi.nlm.nih.gov/42186459/). *Front Genet*. [Gene Therapy / Novel Therapeutics]
Kattner S (2026). [PMID: 41645117](https://pubmed.ncbi.nlm.nih.gov/41645117/). *BMC Infect Dis*. [Basic Science / Preclinical]
Leitão E (2026). [PMID: 41912934](https://pubmed.ncbi.nlm.nih.gov/41912934/). *Nat Genet*. [Review / Meta-Analysis]
Niehaus I (2026). [PMID: 41372632](https://pubmed.ncbi.nlm.nih.gov/41372632/). *EMBO Rep*. [Basic Science / Preclinical]